TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
IOBT
IO Biotech
$
()
IOBT
IO Biotech reports Q4 EPS (40c), consensus (39c)
IOBT
3/5/2024 - 16:44pm
IO Biotech announces first patient dosed in Phase 2 trial of IO102-IO103
IOBT
12/21/2023 - 08:33am
IO Biotech appoints Helen Collins to board of directors
IOBT
,
ELVN
11/13/2023 - 08:26am
IO Biotech reports Q3 EPS (43c), consensus (44c)
IOBT
11/13/2023 - 08:22am
IO Biotech completes enrollment in Phase 3 trial of advanced melanoma
IOBT
,
MRK
11/10/2023 - 08:13am
IO Biotech presents three posters at SITC meeting
IOBT
11/1/2023 - 08:43am
IO Biotech initiated with an Overweight at Piper Sandler
IOBT
9/28/2023 - 05:15am
IO Biotech announces data related to IO102-IO103 in combination with KEYTRUDA
IOBT
,
MRK
9/12/2023 - 08:12am
IO Biotech files to sell 74.13M shares of common stock for holders
IOBT
8/30/2023 - 16:21pm
IO Biotech reports Q2 EPS (74c), consensus (64c)
IOBT
8/11/2023 - 08:37am
IO Biotech appoints Hunter to board of directors
IOBT
8/11/2023 - 08:15am
IO Biotech to sell 37.07M shares at $2.025 in private placement
IOBT
8/7/2023 - 08:40am
IO Biotech announces first patient dosed in trial to evaluate IO102-IO103
IOBT
7/28/2023 - 08:08am
IO Biotech appoints Qasim Ahmad MD, CMO, Faulkner CTO
IOBT
,
NVS
7/18/2023 - 16:12pm
IO Biotech announces achievement of Phase 3 trial recruitment milestone
IOBT
6/14/2023 - 08:10am
dynamic_feed
Breaking News
search
Search
menu
Menu